Related Experiment Video
Updated: Jun 14, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
European cancer data sharing: Analyses of an international survey
Larson Hogstrom1, Arvydas Laurinavicius2, Miguel Giraldez Alvarez3
1Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Background:
Clinical and biomarker data sharing across institutions accelerates cancer research, yet European data sharing practices are not well characterized.
Methods:
We surveyed 75 cancer institutions across 23 European countries on data sharing practices, data standards adoption, and perceived challenges.
Results:
Most institutions (>80 %) actively share data for research. However, adoption of clinical data standards remains fragmented: only 33 % use Fast Healthcare Interoperability Resources (FHIR) and 21 % use the Observational Medical Outcomes Partnership (OMOP) data model. The top non-technical hurdles were General Data Protection Regulation (GDPR) compliance (31 %) and legal challenges (24 %). The leading technical hurdle was interoperability (35 %). Despite challenges, 77 % of institutions aim to expand sharing capabilities.
Conclusions:
Among those surveyed, GDPR compliance and legal complexity are the dominant barriers to European cancer data sharing. Inconsistent data standards adoption poses risks to European Health Data Space (EHDS) implementation. Investments in legal support, interoperability, and personnel are needed to advance cancer research networking.
Related Concept Videos
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
